Satoh, M., and T. Watanabe. 1997. Partial seizures following aseptic meningoencephalitis: An unusual case [in Japanese]. No to Hattatsu 29(4):326-330.

Schessl, J., B. Luther, J. Kirschner, G. Mauff, and R. Korinthenberg. 2006. Infections and vaccinations preceding childhood Guillain-Barré syndrome: A prospective study. European Journal of Pediatrics 165(9):605-612.

Schlenska, G. K. 1977. Unusual neurological complications following tetanus toxoid administration. Journal of Neurology 215(4):299-302.

Schmitt, H. J., A. Schuind, M. Knuf, K. Beutel, H. SchulteWissermann, M. Gahr, R. Schult, J. Folkens, W. Rauh, H. Bogaerts, H. L. Bork, and R. Clemens. 1996. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. Journal of Pediatrics 129(5):695-701.

Schwarz, G., G. Lanzer, and W. F. List. 1988. Acute midbrain syndrome as an adverse reaction to tetanus immunization. Intensive Care Medicine 15(1):53-54.

Sidebotham, P. D., and S. W. Lenton. 1996. Incidence of adverse reactions after administration of high dose diphtheria with tetanus vaccine to school leavers: Retrospective questionnaire study. British Medical Journal 313(7056):533-534.

Sivertsen, B., and P. B. Christensen. 1996. Acute encephalitis. Acta Neurologica Scandinavica 93(2-3):156-159.

Souayah, N., A. Nasar, M. F. K. Suri, and A. I. Qureshi. 2009. Guillain-Barré syndrome after vaccination in United States: Data from the Centers for Disease Control and Prevention/ Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Journal of Clinical Neuromuscular Disease 11(1):1-6.

Stehr, K., J. D. Cherry, U. Heininger, S. Schmitt-Grohe, M. Uberall, S. Laussucq, T. Eckhardt, M. Meyer, R. Engelhardt, and P. Christenson. 1998. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 101(1 I):1-11.

Stetler, H. C., J. R. Mullen, and J. P. Brennan. 1985. Adverse events following immunization with DTP vaccine. Developments in Biological Standardization 61:411-421.

Talbot, E. A., K. H. Brown, K. B. Kirkland, A. L. Baughman, S. A. Halperin, and K. R. Broder. 2010. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 28(50):8001-8007.

Tanaka, M., C. R. Vitek, F. B. Pascual, K. M. Bisgard, J. E. Tate, and T. V. Murphy. 2003. Trends in pertussis among infants in the United States, 1980-1999. Journal of the American Medical Association 290(22):2968-2975.

Teknetzi, P., S. Manios, and V. Katsouyanopoulos. 1983. Neonatal tetanus long-term residual handicaps. Archives of Disease in Childhood 58(1):68-69.

Thanjan, M. T., P. Ramaswamy, W. W. Lai, and I. D. Lytrivi. 2007. Acute myopericarditis after multiple vaccinations in an adolescent: Case report and review of the literature. Pediatrics 119(6):e1400-e1403.

Thierry-Carstensen, B., M. S. Frederiksen, P. H. Andersen, and M. Stellfeld. 2004. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age—a comparison of two vaccines with different amounts of diphtheria toxoid. Vaccine 23(5):668-671.

Tuttle, J., R. T. Chen, H. Rantala, J. D. Cherry, P. H. Rhodes, and S. Hadler. 1997. The risk of Guillain-Barré syndrome after tetanus-toxoid–containing vaccines in adults and children in the United States. American Journal of Public Health 87(12):2045-2048.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement